BridgeMD
Tests treatment safety and results for Seborrheic Dermatitis on the Face
Official title Efficacy of an Antioxidant Moisturizing Serum for Mild to Moderate Seborrheic Dermatitis
ClinicalTrials.gov ID: NCT07433907
What this study is testing
- What it's testing
- This is a 4-week comparison study between the intervention and control sides of the face. Purposive sampling to recruit 13 patients with seborrheic dermatitis will be conducted in this study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age: ≥ 18 years old
- Gender: Male and Female
- Patient who never uses or has stopped using topical corticosteroids/calcineurin inhibitor or other topical treatments exerting anti-inflammatory...
- Patient who does not use cosmetic containing any oxidants or others that exert anti-oxidant effect(s). If there is any, one must refrain from using...
You likely can't join if
- Patients with known cases of underlying HIV/AIDS, neurological condition e.g., Parkinson's disease.
- Patient associated with any autoimmune diseases and other skin diseases
- Patient takes any forms of oral immunotherapy more than 2 months up to the first day of clinical trials.
- Patients continuously use of topical corticosteroids or other anti-inflammatory medicines on regular basis up to the first day of clinical trial.
- Patient who refuses to stop using cosmetic(s) containing anti-oxidants or those exert anti-oxidant effect(s).
- Patient who is allergic to the test product or one of its ingredients.
See the full eligibility criteria
- Age: ≥ 18 years old
- Gender: Male and Female
- Patient who never uses or has stopped using topical corticosteroids/calcineurin inhibitor or other topical treatments exerting anti-inflammatory action (on the face) more than 2 weeks before entering this clinical...
- Patient who does not use cosmetic containing any oxidants or others that exert anti-oxidant effect(s). If there is any, one must refrain from using them more than 2 weeks before entering this clinical trials.
- Patients with known cases of underlying HIV/AIDS, neurological condition e.g., Parkinson's disease.
- Patient associated with any autoimmune diseases and other skin diseases
- Patient takes any forms of oral immunotherapy more than 2 months up to the first day of clinical trials.
- Patients continuously use of topical corticosteroids or other anti-inflammatory medicines on regular basis up to the first day of clinical trial.
- Patient who refuses to stop using cosmetic(s) containing anti-oxidants or those exert anti-oxidant effect(s).
- Patient who is allergic to the test product or one of its ingredients.
- Pregnancy or nursing woman
The study team makes the final eligibility decision.
Where it's taking place
- Ratchathewi, Bangkok, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ratchathewi, Bangkok, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.